Concepedia

Publication | Open Access

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

DOIFull Paper Access

5.1K

Citations

33

References

2005

Year

Martine Piccart, Marion Procter, Brian Leyland‐Jones, Aron Goldhirsch, Michael Untch, Ian Smith, Luca Gianni, José Baselga, Richard H. Bell, Christian Jackisch,
New England Journal of Medicine

Abstract

One year of treatment with trastuzumab after adjuvant chemotherapy significantly improves disease-free survival among women with HER2-positive breast cancer. (ClinicalTrials.gov number, NCT00045032.)

References

YearCitations

Page 1